Curis (CRIS) - Kapitalisasi pasar

Logo grafis Curis, Inc. (CRIS)

The current market value of Curis, Inc. (CRIS) shown on this chart is 0.00. The business minimizes capital expenditures by outsourcing all clinical trials to third-party contractors. A steady cash flow is ensured through royalty payments from the commercialization of drugs by partners. To survive the competition with corporate behemoths, Curis, Inc. (CRIS) focuses on identifying niche therapeutic areas to attract volunteers for its research.

CRIS Curis: Kapitalisasi pasar ing interval 04.07.2022 - 22.10.2026

Rincian metrik lan analitis perusahaan curis.com (CRIS)

Pambiji fundamental perusahaan:Curis Corp CRIS
Sampel barang Curis

Fundamental business resilience is determined by the ability to generate value over the long term. This indicator reflects the product of the current share price and the total number of issued securities, measuring the aggregate market demand for assets. For Curis, Inc. (CRIS), this valuation accounts for the costs of environmental laboratory upgrades and ESG compliance. The trend in the issuer's total market capitalization reflects investor reaction to operational risks. Analyzing the curve helps assess the volatility of the company's value.

Pesaing Curis, Inc. (CRIS)

Nilai pasar BeiGene ONC|Nilai pasar HALO|RevMed - Kapitalisasi pasar|Kapitalisasi pasar Ascentage Pharma Corp AAPG|CG Oncology, Inc. (CGON) - Nilai pasar|URGN - Kapitalisasi pasar|BCAX (Bicara Therapeutics) - Kapitalisasi pasar|Biji pasar Personalis Inc (PSNL)|Kapitalisasi pasar ERAS|Kapitalisasi pasar Delcath Corp (DCTH)|Nilai pasar Y-mAbs Therapeutics YMAB|AURA: Kapitalisasi pasar|Candel - Kapitalisasi pasar|Accuray Inc (ARAY) - Biji pasar|SLS: Kapitalisasi pasar|Nilai pasar Actuate Therapeutics Inc (ACTU)|Nilai pasar Citius Oncology, Inc.|HURA: Nilai pasar|Biji pasar TARA (Protara Therapeutics, Inc.)|FATE (Fate Therapeutics Inc) - Nilai pasar|Kapitalisasi pasar WHWK (Aadi Bioscience)|TCRX - Biji pasar|CSBR: Biji pasar|XBIT - Kapitalisasi pasar|cel-sci.com (CVM) - Nilai pasar|OS Therapies Inc. - Nilai pasar|RADX (Radiopharm Theranostics) - Kapitalisasi pasar|Nilai pasar Artiva ARTV|Kapitalisasi pasar ANL|Biji pasar verupharma.com VERU|Tempest Therapeutics, Inc. - Biji pasar|Kapitalisasi pasar Xilio Therapeutics Inc XLO|RENB - Nilai pasar|Nilai pasar MURA (Mural Oncology plc)|KAPA: Kapitalisasi pasar|OKUR - Kapitalisasi pasar|Nilai pasar CytoMed Therapeutics Ltd|Apollomics Corp (APLM) - Kapitalisasi pasar|Biji pasar THAR (Tharimmune Corp)|ADVB (advanbiomed.com) - Nilai pasar|Kapitalisasi pasar GNPX (Genprex, Inc.)|Kapitalisasi pasar Calidi Biotherapeutics Inc. (CLDI)|SBFM - Nilai pasar|XBIO (Xenetic Biosciences) - Kapitalisasi pasar|SLRX: Kapitalisasi pasar|Biji pasar Kitov Pharma|Biji pasar AONC|beigene.com (BGNE) - Kapitalisasi pasar|Kapitalisasi pasar CKPT|Biji pasar Elevation Oncology Inc. ELEV|Nilai pasar iCAD ICAD|Nilai pasar IKNA|Notable Labs, Ltd. - Kapitalisasi pasar|Kapitalisasi pasar Viracta Therapeutics VIRX|MorphoSys (MOR) - Nilai pasar|NAYA - Kapitalisasi pasar|AAPGV (Ascentage Pharma Group Ltd) - Kapitalisasi pasar